Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3153 of 6351
-
New injection targets Hard-to-Treat cancers
Disease control Recruiting nowThis is a Phase 1, multicenter, open-label dose escalation study to determine the safety and tolerability of intratumoral (IT) injection of tolododekin alfa (ANK-101) in participants with advanced solid tumors who have progressed during or after receiving standard of care (SOC) t…
Phase 1 • Sponsor: Ankyra Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New catheter lock could slash infection risk in young cancer patients
Prevention Recruiting nowInterest of a Taurolidine lock at each catheter closure in the primary prevention of catheter-related endoluminal infection in paediatric oncology. Multicentric, controlled, randomized and double-blind label study.
Sponsor: Institut Curie • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
New brain imaging tech could revolutionize PTSD treatment dosing
Knowledge-focused OngoingThe intent of this study is to establish technical feasibility in a clinical population (PTSD, with or without mild TBI) of personalized TMS-fNIRS technology. Thereby demonstrating the utility of transcranial magnetic stimulation - functional near-infrared spectroscopy (TMS-fNIRS…
Sponsor: Florida State University • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New vaccine aims to wake up immune system against hepatitis b
Disease control OngoingThe objective of this study is to assess the immunogenicity and safety of TVAX-008 injection in antiviral untreated/untreated chronic hepatitis B patients with HBsAg≤20 IU/mL, or HBsAg negative and no seroconversion through an investigator-initiated clinical study.
Early phase 1 • Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Personalized plan aims to cut opioid use in acute pain patients
Disease control Recruiting nowThe aim of this study is to evaluate whether patients who benefit from a personalized pharmaceutical plan (PPP) during their hospitalization, allowing them to be informed and sensitized, are treated for a shorter period of time with strong opioids with a reduced risk of dependenc…
Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Lidocaine may shield patients from Post-ERCP pancreatitis
Prevention Recruiting nowThe goal of this study is, in a population of patients undergoing ERCP surgery, treated preventively with NSAIDs and divided into two groups according to the absence (group 1) or presence (group 2) of intravenous lidocaine in the general anesthesia protocol. The main objective o…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Chill out chemo nerve pain: cold wraps plus compression tested in new trial
Symptom relief Recruiting nowThe investigators aim to determine the effect of cryotherapy wraps plus compression therapy (henceforth referred to as cryocompression) versus cryotherapy wraps alone on the incidence and degree of chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer usi…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
No needles, no pain: new ultrasound aims to spot fatty liver in kids fast
Diagnosis OngoingThis study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents aged 2 - 20 years.
Sponsor: Emory University • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New combo therapy targets early skin cancer: hope or hype?
Disease control PausedThis is an open label, single arm, single-center, pilot study of concurrent phototherapy and POTELIGEO (mogamulizumab-kpkc) in early-stage mycosis fungoides.
Early phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Magic mushroom compound tested for IBS relief
Symptom relief OngoingParticipants with IBS (all subtypes) and with no exclusionary comorbid psychiatric or medical disorders will be enrolled in the study. This study will involve a randomized waitlist control design to investigate the rapid and sustained effects of TRP-8802 following two experiment…
Phase 2 • Sponsor: TRYP Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New knee gel injection aims to ease arthritis pain
Symptom relief CompletedObjective: Identifying the dose of EVI-01 with the best clinical response, balancing the efficacy, safety, and tolerability of the investigational product. Study design: Interventional, dose-finding, three arms, randomized (1:1:1), parallel assignment, double-blind, controlled b…
Sponsor: Aptissen SA • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Wheelchair workout shows promise for MS symptom relief
Symptom relief CompletedThe goal of this randomized controlled clinical trial is to examine the feasibility and initial efficacy of undertaking and delivering a novel, stakeholder-informed exercise training program for wheelchair users with multiple sclerosis. The main questions it aims to answer are: …
Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Electric pulses zap away enlarged tonsils without surgery
Symptom relief CompletedThe purpose of the IRE System is to address the clinical need for reducing the volume of chronic symptomatic hypertrophic tonsil(s) while minimizing side effects and complications. Procedure time will also be reduced. The IRE System is designed to be more comfortable for patients…
Sponsor: ENTire Medical Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New pain block could cut opioid use after gallbladder surgery
Symptom relief Recruiting nowThis trial is a prospective randomized superiority trial comparing sole ropivacaine based local trocar site infiltration to local infiltration combined with laparoscopic ropivacaine TAP block (STALL) in LCC. There are only a few randomized trials comparing sole local anesthesia …
Sponsor: Helsinki University Central Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 16:50 UTC
-
Brain scans may unlock personalized autism therapy for kids
Knowledge-focused CompletedGreater than 80% of children with autism spectrum disorder (ASD) experience sensory differences that make it difficult for them to fully participate in meaningful everyday activities. In this research study, we will use MRI and behavioral methods to assess how sensory interventio…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:39 UTC
-
Measles wipes immune memory: study reveals hidden danger
Knowledge-focused CompletedThe goal of this observational study is to investigate the effects of measles virus (MeV) infection on pre-existing immunity, vaccine response, and susceptibility to subsequent illness in children aged 1-15 either with or without acute MeV infection.
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New drug IBI133 tested in 19 patients with Hard-to-Treat cancers
Disease control CompletedThis is a multicentre, open-label, first-in-human, phase 1/2 study of IBI133 in subjects with unresectable, locally advanced or metastatic solid tumours. Phase 1 section includes three parts, IBI133 dose escalation part, and IBI133 monotherapy dose expansion part. The objective o…
Phase 1/2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Kidney Drug's hidden heart benefits under the microscope
Knowledge-focused OngoingThe goal of this study is to better understand the effects of a sodium-glucose transport protein 2 inhibitor, dapagliflozin, added on to standard of care on heart and lung function and circulating metabolites (substances created when our bodies break down food, drugs, or its own …
Phase 1/2 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Brain training app shows promise for mild cognitive impairment
Symptom relief CompletedCognitive therapy software for improving cognitive function for patients with mild cognitive impairment
Sponsor: Rowan • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Cancer drug trial halted: REC-4881 fails to show promise in Gene-Mutated tumors
Disease control Stopped earlyThis is a multi-center, open-label study to investigate the safety, efficacy and pharmacokinetics of REC-4881 (12 mg PO daily doses) for the treatment of participants with unresectable locally advanced or metastatic solid tumors with AXIN1 or APC mutation.
Phase 2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC